The Role of Selected Dietary Supplements (Vitamin D, Creatine, Folic Acid, and Omega-3 Fatty Acids) in the Management of Depressive Disorders: A Narrative Review
Abstract
Depression is one of the most disabling conditions in the world, and many patients do not achieve full remission with standard treatments.There has been increasing interest in dietary supplements as potential adjuncts to standard treatments for depression.This narrative review examines the evidence regarding vitamin D, creatine, folic acid and omega-3 fatty acids in depressive disorders, with a focus on their potential use alongside standard treatment.A search of PubMed and Google Scholar was performed to identify meta-analyses, systematic reviews and randomised controlled trials evaluating these supplements in the treatment of depression.All four supplements examined have been associated with reductions in depressive symptoms.Vitamin D and omega-3 fatty acids have shown benefits in people with depressive disorders, while folic acid may be beneficial as an adjunct to antidepressants in people with low folate levels.Creatine has also shown some benefits in people taking antidepressants or undergoing cognitive behavioural therapy, although results are not yet conclusive.These findings suggest that dietary supplements could play a role in the treatment of depression, albeit as an adjunct to antidepressant medication.Further studies are required to determine optimal dosing and treatment duration, as well as the patient populations most likely to benefit.
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.